These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 18412244)
21. HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background. Massimi P; Shai A; Lambert P; Banks L Oncogene; 2008 Mar; 27(12):1800-4. PubMed ID: 17934525 [TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification. Hiller T; Poppelreuther S; Stubenrauch F; Iftner T Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1262-7. PubMed ID: 16835321 [TBL] [Abstract][Full Text] [Related]
23. A plant lignan, 3'-O-methyl-nordihydroguaiaretic acid, suppresses papillomavirus E6 protein function, stabilizes p53 protein, and induces apoptosis in cervical tumor cells. Allen KL; Tschantz DR; Awad KS; Lynch WP; DeLucia AL Mol Carcinog; 2007 Jul; 46(7):564-75. PubMed ID: 17393435 [TBL] [Abstract][Full Text] [Related]
24. Comparison of human papillomavirus type 18 (HPV-18) E6-mediated degradation of p53 in vitro and in vivo reveals significant differences based on p53 structure and cell type but little difference with respect to mutants of HPV-18 E6. Gardiol D; Banks L J Gen Virol; 1998 Aug; 79 ( Pt 8)():1963-70. PubMed ID: 9714244 [TBL] [Abstract][Full Text] [Related]
25. Stepwise multipolyubiquitination of p53 by the E6AP-E6 ubiquitin ligase complex. Masuda Y; Saeki Y; Arai N; Kawai H; Kukimoto I; Tanaka K; Masutani C J Biol Chem; 2019 Oct; 294(41):14860-14875. PubMed ID: 31492752 [TBL] [Abstract][Full Text] [Related]
26. Pitx2a binds to human papillomavirus type 18 E6 protein and inhibits E6-mediated P53 degradation in HeLa cells. Wei Q J Biol Chem; 2005 Nov; 280(45):37790-7. PubMed ID: 16129685 [TBL] [Abstract][Full Text] [Related]
27. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer. Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297 [TBL] [Abstract][Full Text] [Related]
28. Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells. Sun SY; Yue P; Wu GS; El-Deiry WS; Shroot B; Hong WK; Lotan R Cancer Res; 1999 Jun; 59(12):2829-33. PubMed ID: 10383141 [TBL] [Abstract][Full Text] [Related]
29. HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation. Thomas M; Glaunsinger B; Pim D; Javier R; Banks L Oncogene; 2001 Sep; 20(39):5431-9. PubMed ID: 11571640 [TBL] [Abstract][Full Text] [Related]
30. Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation. Alarcón R; Koumenis C; Geyer RK; Maki CG; Giaccia AJ Cancer Res; 1999 Dec; 59(24):6046-51. PubMed ID: 10626788 [TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation. Liu Y; McKalip A; Herman B J Cell Biochem; 2000 May; 78(2):334-49. PubMed ID: 10842327 [TBL] [Abstract][Full Text] [Related]
32. Felis catus papillomavirus type-2 E6 binds to E6AP, promotes E6AP/p53 binding and enhances p53 proteasomal degradation. Altamura G; Power K; Martano M; Degli Uberti B; Galiero G; De Luca G; Maiolino P; Borzacchiello G Sci Rep; 2018 Dec; 8(1):17529. PubMed ID: 30510267 [TBL] [Abstract][Full Text] [Related]
33. Down regulation of p53 with HPV E6 delays and modifies cell death in oxidant response of human diploid fibroblasts: an apoptosis-like cell death associated with mitosis. Chen QM; Merrett JB; Dilley T; Purdom S Oncogene; 2002 Aug; 21(34):5313-24. PubMed ID: 12149652 [TBL] [Abstract][Full Text] [Related]
34. The domain of p53 required for binding HPV 16 E6 is separable from the degradation domain. Mansur CP; Marcus B; Dalal S; Androphy EJ Oncogene; 1995 Feb; 10(3):457-65. PubMed ID: 7845670 [TBL] [Abstract][Full Text] [Related]
35. HPV16 E6 confers p53-dependent and p53-independent phenotypes in the epidermis of mice deficient for E6AP. Shai A; Nguyen ML; Wagstaff J; Jiang YH; Lambert PF Oncogene; 2007 May; 26(23):3321-8. PubMed ID: 17130828 [TBL] [Abstract][Full Text] [Related]
36. Functional consequences of directed mutations in human papillomavirus E6 proteins: abrogation of p53-mediated cell cycle arrest correlates with p53 binding and degradation in vitro. Slebos RJ; Kessis TD; Chen AW; Han SM; Hedrick L; Cho KR Virology; 1995 Apr; 208(1):111-20. PubMed ID: 11831691 [TBL] [Abstract][Full Text] [Related]
37. Resistance to apoptosis of HPV 16-infected laryngeal cancer cells is associated with decreased Bak and increased Bcl-2 expression. Du J; Chen GG; Vlantis AC; Chan PK; Tsang RK; van Hasselt CA Cancer Lett; 2004 Mar; 205(1):81-8. PubMed ID: 15036664 [TBL] [Abstract][Full Text] [Related]
38. A ubiquitin variant-based affinity approach selectively identifies substrates of the ubiquitin ligase E6AP in complex with HPV-11 E6 or HPV-16 E6. Ebner FA; Sailer C; Eichbichler D; Jansen J; Sladewska-Marquardt A; Stengel F; Scheffner M J Biol Chem; 2020 Oct; 295(44):15070-15082. PubMed ID: 32855237 [TBL] [Abstract][Full Text] [Related]
39. Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation. Thomas M; Matlashewski G; Pim D; Banks L Oncogene; 1996 Jul; 13(2):265-73. PubMed ID: 8710365 [TBL] [Abstract][Full Text] [Related]
40. The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Thomas M; Pim D; Banks L Oncogene; 1999 Dec; 18(53):7690-700. PubMed ID: 10618709 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]